Skip to content
PubMed This is a summary of 103 peer-reviewed journal articles Updated
Infectious Diseases · HIV Infection

HIV: A Patient Guide

At a Glance

HIV is a lifelong infection, but modern antiretroviral therapy can suppress the virus, protect the immune system, and support a near-normal life expectancy. When viral load stays below 200 copies/mL for at least six months, U=U means there is zero risk of sexual transmission.

Receiving an HIV diagnosis is a significant life event that often brings a wave of complex emotions. However, the most critical thing to understand today is that HIV is highly treatable and often manageable long term with consistent care [1]. While it remains a serious lifelong infection, people living with HIV who have access to and tolerate modern Antiretroviral Therapy (ART) can generally expect a life expectancy that is near normal [2] [3].

The cornerstone of modern HIV care is the “rapid start” approach. Research has shown that starting medication as soon as possible after diagnosis—sometimes even on the same day—is an excellent way to protect your health for most people [1]. However, clinicians may need to confirm the diagnosis, evaluate prior treatment, assess pregnancy and HBV status, or rule out severe central nervous system infections (like cryptococcal or TB meningitis) before choosing the safest timing for you. By quickly stopping the virus from replicating, you prevent it from damaging your immune system. Clinical trials have proven that starting treatment early, even when you feel perfectly healthy, significantly lowers the risk of serious AIDS-related illnesses, non-AIDS-related complications, and death [4] [5].

One of the most empowering breakthroughs in recent years is the concept of Undetectable = Untransmittable (U=U). Scientific evidence has definitively shown that when a person’s viral load is durably suppressed to an undetectable level (defined as fewer than 200 copies/mL) for at least six months, there is zero risk of passing HIV to sexual partners [6] [7]. This discovery has transformed the social and emotional landscape of living with HIV, allowing for healthy, confident relationships without the fear of sexual transmission [8].

As you move forward, the focus of your care will gradually shift from simply managing the virus to protecting your long-term, overall wellness. Because HIV can cause persistent low-level immune activation, people living with the virus may face slightly higher risks for age-related “comorbidities,” such as cardiovascular disease, bone density loss, or kidney issues [9] [10]. This means that while your HIV specialist is vital for managing your ART, a strong relationship with a primary care provider is equally important for routine screenings, vaccinations, and heart health [11]. By staying engaged with your healthcare team and taking your medication daily, you can look forward to a long, healthy, and vibrant life [12].

Common questions in this guide

Can HIV be treated, and can people with HIV live a long life?
HIV cannot currently be cured, but daily antiretroviral therapy can control the virus and protect the immune system. With consistent treatment and ongoing medical care, many people with HIV can have a near-normal life expectancy and live healthy, active lives.
How soon after an HIV diagnosis should treatment begin?
Many people can start antiretroviral therapy as soon as possible, sometimes on the day of diagnosis. A clinician may first confirm the result, review previous treatment, assess pregnancy or hepatitis B status, or check for serious central nervous system infections before selecting the safest timing.
What does U=U mean for someone taking HIV treatment?
Undetectable equals untransmittable means that a person with HIV who maintains a viral load below 200 copies per milliliter for at least six months has zero risk of transmitting HIV through sex. Regular viral-load testing helps confirm that suppression is being maintained.
What health problems should be monitored while living with HIV?
Even when HIV is controlled, ongoing care should include attention to heart health, kidney function, and bone density because people living with HIV may have slightly higher risks for these problems. A primary care clinician and HIV specialist can coordinate screenings, vaccinations, and treatment.
How often should viral load be checked when it is undetectable?
Your clinician will decide how often to check viral load based on your treatment history, recent results, and overall health. Regular testing confirms that HIV remains suppressed and supports U=U, so ask your HIV care team for the schedule that fits your situation.
Why do I need both an HIV specialist and a primary care clinician?
An HIV specialist manages antiretroviral therapy and viral suppression, while primary care helps with screenings, vaccinations, and overall health, including heart, kidney, and bone care. Coordinated care lets both clinicians address HIV and long-term wellness together.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current health, how quickly can I start treatment, and do we need to wait for any specific tests or rule out any infections first?
  2. 2.What is my current cardiovascular risk, and what should we be monitoring to protect my heart, kidneys, and bones as I age?
  3. 3.How often will we check my viral load to ensure I am maintaining 'undetectable' status for U=U?
  4. 4.Since I’ll need both an HIV specialist and primary care, how will you coordinate with my other doctors to manage my overall health?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Same-day and rapid initiation of antiretroviral therapy in people living with HIV in Asia. How far have we come?

    Hung CC, Phanuphak N, Wong CS, et al.

    HIV medicine 2022; (23 Suppl 4()):3-14 doi:10.1111/hiv.13410.

    PMID: 36254390
  2. 2

    Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.

    The lancet. HIV 2017; (4(8)):e349-e356 doi:10.1016/S2352-3018(17)30066-8.

    PMID: 28501495
  3. 3

    Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016.

    Marcus JL, Leyden WA, Alexeeff SE, et al.

    JAMA network open 2020; (3(6)):e207954 doi:10.1001/jamanetworkopen.2020.7954.

    PMID: 32539152
  4. 4

    Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

    , Lundgren JD, Babiker AG, et al.

    The New England journal of medicine 2015; (373(9)):795-807 doi:10.1056/NEJMoa1506816.

    PMID: 26192873
  5. 5

    A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

    , Danel C, Moh R, et al.

    The New England journal of medicine 2015; (373(9)):808-22 doi:10.1056/NEJMoa1507198.

    PMID: 26193126
  6. 6

    Risk of sexual transmission of HIV in the context of viral load suppression.

    Djiadeu P, Begum H, Sabourin S, et al.

    Canada communicable disease report = Releve des maladies transmissibles au Canada 2023; (49(11-12)):457-464 doi:10.14745/ccdr.v49i1112a01.

    PMID: 38504878
  7. 7

    Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

    Rodger AJ, Cambiano V, Bruun T, et al.

    Lancet (London, England) 2019; (393(10189)):2428-2438 doi:10.1016/S0140-6736(19)30418-0.

    PMID: 31056293
  8. 8

    Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review.

    LeMessurier J, Traversy G, Varsaneux O, et al.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2018; (190(46)):E1350-E1360 doi:10.1503/cmaj.180311.

    PMID: 30455270
  9. 9

    Geriatric Syndromes in Older HIV-Infected Adults.

    Greene M, Covinsky KE, Valcour V, et al.

    Journal of acquired immune deficiency syndromes (1999) 2015; (69(2)):161-7 doi:10.1097/QAI.0000000000000556.

    PMID: 26009828
  10. 10

    Managing HIV-associated inflammation and ageing in the era of modern ART.

    Bloch M, John M, Smith D, et al.

    HIV medicine 2020; (21 Suppl 3()):2-16 doi:10.1111/hiv.12952.

    PMID: 33022087
  11. 11

    Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV.

    Martin-Iguacel R, Negredo E, Peck R, Friis-Møller N

    Current hypertension reports 2016; (18(6)):46 doi:10.1007/s11906-016-0656-3.

    PMID: 27131801
  12. 12

    Rapid initiation of antiretroviral therapy for people living with HIV.

    Mateo-Urdiales A, Johnson S, Smith R, et al.

    The Cochrane database of systematic reviews 2019; (6()):CD012962 doi:10.1002/14651858.CD012962.pub2.

    PMID: 31206168

This HIV guide is for informational purposes only and does not constitute medical advice. Your HIV specialist and primary care clinician can tailor treatment, monitoring, and support to your situation.

Get notified when new evidence is published on HIV infectious disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.